- Pharmaceutical companies
- Gilead Sciences
Gilead Sciences
Phone: +16505743000, 800-GILEAD-5 (800-445-3235)
Fax: (650) 578-9264
E-mail: public_affairs@gilead.com, corporate_development@gilead.com
Type | Public |
---|---|
Traded as |
|
Industry |
|
Founded | June 22, 1987 (1987-06-22) |
Headquarters | Foster City, California, United States |
Area served | Worldwide |
Key people |
|
Products |
|
Revenue | US$27.31 billion (2021) |
Operating income | US$9.92 billion (2021) |
Net income | US$6.23 billion (2021) |
Total assets | US$67.95 billion (2021) |
Total equity | US$21.06 billion (2021) |
Number of employees | 14,400 (2021) |
At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases. Through bold and transformative science, we’re creating possibilities that have the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.
For detailed contact information visit location pages below.
Gilead Sciences's locations around the world
Europe
North America
Africa
Oceania
Clinical Trials sponsored by Gilead Sciences
-
Gilead SciencesNon ancora reclutamento
-
Gilead SciencesReclutamento
-
Gilead SciencesReclutamentoColite ulcerosaStati Uniti
-
Gilead SciencesReclutamentoTumori solidiAustralia, Stati Uniti, Canada
-
Gilead SciencesReclutamentoInfezione cronica da epatite DStati Uniti
-
Gilead SciencesReclutamentoInfezione cronica da epatite DAustria, Francia, Germania, Spagna, Romania
-
Gilead SciencesReclutamentoInfezione da HIV-1Stati Uniti, Tailandia, Repubblica Dominicana
-
Gilead SciencesAttivo, non reclutanteCancro colorettale metastaticoStati Uniti, Spagna, Australia, Hong Kong, Francia, Belgio, Canada, Porto Rico, Germania, Italia
-
Gilead SciencesTerminatoLeucemia mieloide acutaStati Uniti, Spagna, Germania, Israele, Regno Unito, Taiwan, Corea, Repubblica di, Australia, Belgio, Hong Kong, Francia, Olanda, Italia, Canada, Austria, Cechia, Ungheria, Norvegia, Polonia, Svizzera
-
Gilead SciencesAttivo, non reclutanteTumore solido metastaticoStati Uniti, Spagna, Francia, Hong Kong, Australia, Belgio, Taiwan, Canada